New Delhi, 14 Mar, 2015: The Medical Affairs function within the pharmaceutical sector plays an important role in new product launches, starting from the pre-launch phase and extending well beyond the launch date.
Critical aspects of launch support that Medical Affairs leaders need to focus on are early stage thought leader (TL) interaction, successful TL targeting, alignment of commercial training to demands of key stakeholders and launch resource management, according to a new study from research and consulting leader Best Practices, LLC.
“Medical Affairs’ Role in Ensuring Excellence in Product Launch,” highlights the launch activities and critical success factors that go into providing effective Medical Affairs launch support for new products.
Key study objectives included:
Findings from this primary research project provide evidence-based insights and metrics that will serve as a reference point for Medical Affairs leaders seeking to create and execute value-based launch strategies.
Best Practices, LLC engaged 28 executives from 24 leading biopharmaceutical companies within mature markets. Research analysts also conducted deep-dive interviews with five selected Medical Affairs executives.
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…